ArticleBlood advances2017

Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide.

Franco Aversa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.